Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Daniel Prieto-Alhambra has been awarded the 'Special ISPE award for contributions to public health associated with the COVID-19 pandemic.'

Dani receiving his award from ISPE
Dani (second from right) with his ISPE award recognising his contribution to COVID-19 research

The award was presented at the 38th International Conference on Pharmacoepidemiology, which took place in Copenhagen, in recognition of Dani's demonstrable impact on public health related to the COVID-19 pandemic through his work in Pharmacoepidemiology.

Daniel is the Professor of Pharmaco- and Device Epidemiology and Section Head for Health Data Sciences at the Botnar Research Centre, NDORMS, University of Oxford.

As a member of the European Health Data & Evidence Network (EHDEN) and the Observational Health Data Sciences and Informatics (OHDSI), Dani has studied the impacts and effects of COVID-19 throughout the pandemic to better inform the global response.

Projects included:

  • Projects exploring the risks and efficacy of the COVID-19 vaccines, including the impact on neurological disorders;
  • An international study to understand the characteristics of patients suffering from COVID-19 in greater detail;
  • Research to understand the safety profile and risks of Hydroxychloroquine, that was considered a potential COVID-19 treatment;
  • And hosting a COVID-19 virtual study-a-thon to inform healthcare decision-making in response to the global pandemic.

Commenting on the award Daniel said: "All senior awards recognise the work of many, not one individual. This one in particular acknowledges the work of my team at the Botnar Research Centre (University of Oxford), Erasmus MC Rotterdam, and colleagues in the EHDEN and OHDSI communities who went the extra mile for months. We rallied to generate actionable evidence on the impact of COVID-19, and for the monitoring of COVID vaccine safety."

Similar stories

NIHR Fellowships awarded to NDORMS researchers

Congratulations to Eileen Morrow and Mae Chester-Jones who have received NIHR Doctoral Fellowships

ORUK Early Career Research Fellowship awarded to NDORMS researcher

Congratulations to Jack Tu who has been awarded an Orthopaedic Research UK Early Career Research Fellowship to explore the cause of knee pain after total knee replacement.

OCTRU - delivering answers to important clinical questions

The Oxford Clinical Trials Research Unit (OCTRU) has received NIHR benchmarking results and offers excellent value for money according to the report

Unhelpful thoughts about fracture symptoms hinder recovery

The importance of mindsets and feelings about fracture symptoms have been shown to be a key factor in recovery of musculoskeletal conditions.

Fat tissues can play a protective role against inflammation in the intestine

A new study in The EMBO Journal has revealed how fat tissues might provide a protective role in intestinal inflammation opening new lines of research into the treatment of inflammatory bowel diseases.

NDORMS researchers awarded Sir Henry Wellcome Fellowships

Kennedy Institute researchers Mariana Borsa and Edward Jenkins have both been awarded Sir Henry Wellcome Postdoctoral Fellowships, which give recently qualified postdoctoral researchers the opportunity to start independent research careers.